CAP-003

· Capsida Biotherapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CAP-003, covering 2025-10-08 to 2025-10-08. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease [Phase 1, Phase 2]

See pricing